Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: United States Clear all

309 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20033
20045
20054
200612
20077
200819
200913
201023
201120
201214
201317
201410
201511
201613
201715
201813
201917
20209
202124
202212
202315
202412
20257
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed176
Terminated59
Recruiting32
Withdrawn16
Active, not recruiting14
Unknown status7
Not yet recruiting3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion36
United Therapeutics34
Novartis Pharmaceuticals11
Mayo Clinic8
University of Pennsylvania8
Vanderbilt University Medical Center8
Lung Biotechnology PBC6
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA5
Bayer5
Gilead Sciences5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension309
Hypertension, Pulmonary90
Familial Primary Pulmonary Hypertension18
Hypertension12
Lung Diseases, Interstitial12
Connective Tissue Diseases10
Lung Diseases10
Heart Failure8
Idiopathic Pulmonary Fibrosis7
Cardiovascular Diseases6

Trials

Showing 1 to 25 of 309. Each trial links to its page on Pharma Observatory.

209 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.